Skip to main content
Saqr Alsakarneh, MD, Internal Medicine, Kansas City, MO

SaqrAlsakarnehMD, MS(c)

Internal Medicine Kansas City, MO

Gastroenterology

Internal Medicine resident at the University of Missouri-Kansas City. Interested in Gastroenterology and Hepatology. Master's Degree in Bioinformatics and Clinical Research. Has a special interest in gender and racial disparities in gastrointestinal diseases. Trend analysis, Systematic Review, Metanalysis, Med Education, GI cancers, Hepatology. Trained on SPSS, R, SAS, Stata, Excel

Dr. Alsakarneh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Alsakarneh's full profile

Already have an account?

  • Office

    2301 Holmes St
    Kansas City, MO 64108
    Phone+1 816-522-5656

Education & Training

  • University of Missouri-Kansas City School of Medicine
    University of Missouri-Kansas City School of Medicine MSc, Clinical Research, 2023 - 2025
  • University of Missouri-Kansas City School of Medicine
    University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 2022 - 2025
  • Al-Balqa Applied University Faculty of Medicine
    Al-Balqa Applied University Faculty of MedicineClass of 2021

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2022 - 2025
  • ECFMGECFMG

Awards, Honors, & Recognition

  • Poster of Distinction Digestive Disease Week (DDW), 2024
  • Sigma Xi Honor Society Sigma Xi, 2024
  • 2024 AGA Abstract Award for Health Disparities Research American Gastroenterology Association, 2024
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Women, Black patients underrepresented in US-based clinical trials for LT
    Women, Black patients underrepresented in US-based clinical trials for LTMay 17th, 2024
  • CRC incidence on the rise among younger women, ‘demands heightened attention’
    CRC incidence on the rise among younger women, ‘demands heightened attention’May 17th, 2024
  • U.S. CRC Rates Drop 25% Over Past 30 Years
    U.S. CRC Rates Drop 25% Over Past 30 YearsOctober 25th, 2023

Committees

  • Collaborator, Global Burden of Diseases Study 2022 - Present
  • Co-founder, HeForShe 2017 - Present

Professional Memberships

Other Languages

  • Arabic, French